scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Martina Stella | Q57049450 |
Isabella Piga | Q59036680 | ||
Fulvio Magni | Q38545045 | ||
P2093 | author name string | Andrew Smith | |
Marina Del Puppo | |||
Vanna Denti | |||
Manuel Galli | |||
P2860 | cites work | Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue | Q75204913 |
Human neutrophil peptides 1, 2 and 3 (HNP 1-3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis | Q84352152 | ||
Novel Insights into the Roles of Rho Kinase in Cancer | Q26771368 | ||
Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids | Q26996516 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Recent advances in mass spectrometry-based proteomics of gastric cancer | Q28075514 | ||
Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
Mass spectrometry imaging with high resolution in mass and space | Q28383071 | ||
Bagging predictors | Q29013802 | ||
Absolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues. | Q30371747 | ||
Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry | Q30463611 | ||
Mass spectrometric imaging for biomedical tissue analysis | Q30475508 | ||
High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry | Q30479894 | ||
Sublimation as a method of matrix application for mass spectrometric imaging | Q30493588 | ||
Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis | Q30498661 | ||
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors | Q30828511 | ||
Improving tissue preparation for matrix-assisted laser desorption ionization mass spectrometry imaging. Part 1: using microspotting | Q30872966 | ||
On-tissue protein identification and imaging by MALDI-ion mobility mass spectrometry. | Q30900112 | ||
Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation | Q30975387 | ||
Normalization in MALDI-TOF imaging datasets of proteins: practical considerations | Q31004927 | ||
Human neutrophil peptides 1-3 as gastric cancer tissue markers measured by MALDI-imaging mass spectrometry: implications for infiltrated neutrophils as a tumor target | Q31047432 | ||
Data-driven identification of prognostic tumor subpopulations using spatially mapped t-SNE of mass spectrometry imaging data | Q31139672 | ||
A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples | Q31141990 | ||
Matrix pre-coated targets for high throughput MALDI imaging of proteins | Q31160700 | ||
Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. | Q32171247 | ||
MALDI-MS direct tissue analysis of proteins: Improving signal sensitivity using organic treatments | Q33260235 | ||
MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue | Q33344986 | ||
Protein and peptides in pictures: imaging with MALDI mass spectrometry | Q33361378 | ||
On the Importance of Mathematical Methods for Analysis of MALDI-Imaging Mass Spectrometry Data. | Q51416958 | ||
Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. | Q51456357 | ||
Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray. | Q53304040 | ||
MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers | Q33430326 | ||
Aniline/alpha-cyano-4-hydroxycinnamic acid is a highly versatile ionic liquid for matrix-assisted laser desorption/ionization mass spectrometry | Q33438556 | ||
Sample preparation issues for tissue imaging by imaging MS. | Q33439020 | ||
Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue | Q33624031 | ||
MALDI mass spectrometry imaging of proteins exceeding 30,000 daltons. | Q33677078 | ||
MALDI imaging and profiling MS of higher mass proteins from tissue | Q33688769 | ||
Spatial segmentation of imaging mass spectrometry data with edge-preserving image denoising and clustering | Q33721160 | ||
Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier | Q33740970 | ||
A simple desalting method for direct MALDI mass spectrometry profiling of tissue lipids | Q33803574 | ||
Matrix pre-coated MALDI MS targets for small molecule imaging in tissues | Q33864795 | ||
Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging | Q34001479 | ||
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer | Q34052933 | ||
MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma | Q34172339 | ||
On the importance of mathematical methods for analysis of MALDI-imaging mass spectrometry data | Q34203599 | ||
Conductive carbon tape used for support and mounting of both whole animal and fragile heat-treated tissue sections for MALDI MS imaging and quantitation. | Q34337726 | ||
Detection of high molecular weight proteins by MALDI imaging mass spectrometry. | Q34557652 | ||
Gastric cancer: current status of diagnosis and treatment | Q34657361 | ||
Matrix-assisted laser desorption/ionization matrices for negative mode metabolomics | Q34809428 | ||
A mimetic tissue model for the quantification of drug distributions by MALDI imaging mass spectrometry | Q34984942 | ||
Label-free in situ monitoring of histone deacetylase drug target engagement by matrix-assisted laser desorption ionization-mass spectrometry biotyping and imaging. | Q35100040 | ||
Mass spectrometry imaging for drugs and metabolites | Q35151495 | ||
Advances in tissue section preparation for MALDI imaging MS. | Q35164791 | ||
Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma | Q35166408 | ||
MALDI mass spectrometry imaging of bioactive lipids in mouse brain with a Synapt G2-S mass spectrometer operated at elevated pressure: improving the analytical sensitivity and the lateral resolution to ten micrometers. | Q35203726 | ||
De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry. | Q35243470 | ||
Proteomic and metabolic prediction of response to therapy in gastric cancer | Q35336183 | ||
Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirs | Q35385971 | ||
MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (review). | Q35497515 | ||
Mass spectrometry imaging in drug development | Q35530802 | ||
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues. | Q35543504 | ||
MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice | Q35549222 | ||
Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer | Q35573943 | ||
Alternative surfactants for improved efficiency of in situ tryptic proteolysis of fingermarks. | Q35578123 | ||
Imaging mass spectrometry increased resolution using 2-mercaptobenzothiazole and 2,5-diaminonaphtalene matrices: application to lipid distribution in human colon. | Q35611870 | ||
Benchmark datasets for 3D MALDI- and DESI-imaging mass spectrometry | Q35622241 | ||
Electric Field-Assisted Matrix Coating Method Enhances the Detection of Small Molecule Metabolites for Mass Spectrometry Imaging | Q35643062 | ||
Use of advantageous, volatile matrices enabled by next-generation high-speed matrix-assisted laser desorption/ionization time-of-flight imaging employing a scanning laser beam. | Q35828808 | ||
Tissue MALDI Mass Spectrometry Imaging (MALDI MSI) of Peptides | Q35877476 | ||
3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Q35925481 | ||
MALDI mass spectrometry imaging: A cutting-edge tool for fundamental and clinical histopathology | Q36020378 | ||
Machine learning approaches in MALDI-MSI: clinical applications | Q36056901 | ||
Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section | Q36066970 | ||
High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue | Q36077253 | ||
Recent advancements in matrix-assisted laser desorption/ionization mass spectrometry imaging | Q36149952 | ||
MALDI IMS and Cancer Tissue Microarrays | Q36256717 | ||
N-Glycan matrix-assisted laser desorption/ionization mass spectrometry imaging protocol for formalin-fixed paraffin-embedded tissues. | Q36300374 | ||
Fresh Frozen Versus Formalin-Fixed Paraffin Embedded for Mass Spectrometry Imaging | Q36376214 | ||
Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer | Q37246054 | ||
Next-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis | Q37426939 | ||
Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences | Q38007274 | ||
Imaging mass spectrometry statistical analysis | Q38022386 | ||
MALDI mass spectrometry imaging of formalin-fixed paraffin-embedded tissues in clinical research | Q38212605 | ||
Glycosylation in cancer: mechanisms and clinical implications | Q38569702 | ||
Principal component analysis: a review and recent developments | Q38764960 | ||
Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics | Q38935383 | ||
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. | Q38961789 | ||
Signal preprocessing, multivariate analysis and software tools for MA(LDI)-TOF mass spectrometry imaging for biological applications | Q39012950 | ||
Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria | Q39165098 | ||
Three-dimensional imaging MS of lipids in atherosclerotic plaques: Open-source methods for reconstruction and analysis. | Q39935701 | ||
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome | Q42366594 | ||
Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion | Q46161556 | ||
Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor | Q47136892 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | matrix-assisted laser desorption/ionization | Q736400 |
stomach neoplasm | Q4335552 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P577 | publication date | 2017-12-01 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging in the Study of Gastric Cancer: A Mini Review | |
P478 | volume | 18 |
Q61444427 | High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China |
Q98166064 | Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer |
Q55025461 | Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets. |
Q57476064 | Molecular Features Distinguish Gastric Cancer Subtypes |
Q92192821 | Proteome Imaging: From Classic to Modern Mass Spectrometry-Based Molecular Histology |
Q100736448 | Proteomics for the study of new biomarkers in Fabry disease: State of the art |
Search more.